Wells Fargo Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); A Few Hiccups, But Expect Positive N-T Data

Go back to Wells Fargo Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); A Few Hiccups, But Expect Positive N-T Data